Cargando…

SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis

Patients with rheumatoid arthritis (RA) are at increased risk for cardiovascular disease (CVD). Risk chart algorithms, such as the Systematic Coronary Risk Assessment (SCORE), often underestimate the risk of CVD in patients with RA. In this sense, the use of noninvasive tools, such as the carotid ul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferraz-Amaro, Iván, Corrales, Alfonso, Atienza-Mateo, Belén, Vegas-Revenga, Nuria, Prieto-Peña, Diana, Sánchez-Martín, Julio, Almeida, Cristina, Quevedo-Abeledo, Juan Carlos, Blanco, Ricardo, González-Gay, Miguel Á.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700102/ https://www.ncbi.nlm.nih.gov/pubmed/34943599 http://dx.doi.org/10.3390/diagnostics11122363

Ejemplares similares

Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363
por: Ferraz-Amaro, Iván, et al.
Publicado: (2022)

Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

The Performance of Vascular Age in the Assessment of Cardiovascular Risk of Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2020)

Misperception of the Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Alonso-Molero, Jéssica, et al.
Publicado: (2020)

Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

SCORE2 versus SCORE in patients with systemic lupus erythematosus
por: Quevedo-Abeledo, Juan Carlos, et al.
Publicado: (2022)

Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis
por: Pulito-Cueto, Verónica, et al.
Publicado: (2022)

Red Cell Distribution Width Association with Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

The Number of Traditional Cardiovascular Risk Factors Is Independently Correlated with Disease Activity in Patients with Psoriatic Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2020)

Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis
por: Martín-González, Candelaria, et al.
Publicado: (2022)

Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

The Ratio of Monocytes to HDL-Cholesterol Is Associated with Cardiovascular Risk and Insulin Resistance in Patients with Rheumatoid Arthritis
por: Romo-Cordero, Alejandro, et al.
Publicado: (2023)

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
por: de Armas-Rillo, Laura, et al.
Publicado: (2022)

Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity
por: González-Sierra, Marta, et al.
Publicado: (2023)

Endothelial Progenitor Cells as a Potential Biomarker in Interstitial Lung Disease Associated with Rheumatoid Arthritis
por: Pulito-Cueto, Verónica, et al.
Publicado: (2020)

A Review of the Dermatological Complications of Giant Cell Arteritis
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Metabolic Syndrome in Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2013)

SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis
por: Gómez-Vaquero, Carmen, et al.
Publicado: (2013)

Imaging Tests in the Early Diagnosis of Giant Cell Arteritis
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients
por: Ferraz-Amaro, Iván, et al.
Publicado: (2013)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Incretins in patients with rheumatoid arthritis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Blood Composite Scores in Patients with Systemic Lupus Erythematosus
por: Mercader-Salvans, Júlia, et al.
Publicado: (2023)

Apolipoprotein C-III in patients with systemic lupus erythematosus
por: Martín-González, Candelaria, et al.
Publicado: (2022)

Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review
por: Atienza-Mateo, Belén, et al.
Publicado: (2020)

Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study
por: Corrales, Alfonso, et al.
Publicado: (2015)

Advances in the Treatment of Giant Cell Arteritis
por: Castañeda, Santos, et al.
Publicado: (2022)

The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation †
por: Atienza-Mateo, Belén, et al.
Publicado: (2020)

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus
por: Sánchez-Pérez, Hiurma, et al.
Publicado: (2020)

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus
por: Quevedo-Abeledo, Juan Carlos, et al.
Publicado: (2022)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2022)

Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2023)

Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients
por: López-Mejías, Raquel, et al.
Publicado: (2015)

Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?
por: Pulito-Cueto, Verónica, et al.
Publicado: (2022)

Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients
por: Pulito-Cueto, Verónica, et al.
Publicado: (2021)

Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases
por: Pulito-Cueto, Verónica, et al.
Publicado: (2023)

Atherosclerosis in Rheumatoid Arthritis
por: González-Gay, Miguel A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4kr10bfvjhlsuk6h4n32r8u7kr